1.0GCC Regulatory Affairs Pharma Summithttps://pramagcc.com/raadmin@ra2025https://pramagcc.com/ra/author/adminra2025/MS. FARIDA ALAYAN - GCC Regulatory Affairs Pharma Summitrich600338<blockquote class="wp-embedded-content" data-secret="4N9usARPyP"><a href="https://pramagcc.com/ra/member/ms-farida-alayan/">MS. FARIDA ALAYAN</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pramagcc.com/ra/member/ms-farida-alayan/embed/#?secret=4N9usARPyP" width="600" height="338" title="“MS. FARIDA ALAYAN” — GCC Regulatory Affairs Pharma Summit" data-secret="4N9usARPyP" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pramagcc.com/ra/wp-includes/js/wp-embed.min.js
</script>
https://pramagcc.com/ra/wp-content/uploads/2024/09/Farida-copy.png11271127Ms. Farida Joined the generics pharmaceutical industry in 2010 as the RA officer in the Jordanian Pharmaceutical Manufacturing Company (JPM). Since then, she worked in several positions in RA and licensing field during the past 12 years. In 2013, Farida was introduced to the Intellectual Property (IP) field. Until April 2022, she was the Intellectual […]